Pharmacokinetics trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction

Abstract

Cocaine is known to increase brain dopamine at supranormal levels in comparison to alternative nondrug rewards. According to the dopamine hypothesis of addiction, this abnormally large dopamine response would explain why cocaine use is initially highly rewarding and addictive. Though resting on solid neuroscientific foundations, this hypothesis has nevertheless proven difficult to reconcile with research on cocaine choice in experimental animals. When facing a choice between an intravenous bolus of cocaine and a nondrug alternative (e.g., sweet water), both delivered immediately after choice, rats do not choose the drug, as would be predicted, but instead develop a strong preference for the nondrug alternative. Here we report evidence that reconciles this finding with the dopamine hypothesis of addiction. First, a systematic literature analysis revealed that the delays of effects of intravenous cocaine on nucleus accumbens dopamine are of the order of tens of seconds and are considerably longer than those of nondrug reward. Second, this was confirmed by measuring response times to cocaine omission during self-administration as a behavioral proxy of these delays. Finally, when the influence of the drug delays was reduced during choice by adding an increasing delay to both the drug and nondrug rewards, rats shifted their choice to cocaine. Overall, this study suggests that cocaine is indeed supranormal in reward magnitude, as postulated by the dopamine hypothesis of addiction, but is less preferred during choice because its pharmacokinetics makes it an inherently more delayed reward than the alternative. Reframing previous drug choice studies in rats as intertemporal choice studies reveals that the discounting effects of delays spare no rewards, including supranormal ones, and that during choice, pharmacokinetics trumps pharmacodynamics.

Oxytocin and orexin systems bidirectionally regulate the ability of opioid cues to bias reward seeking

“…This may account, in part, for the more equal preference between food and heroin observed under the choice conditions used here. Alternatively, more recent work suggests that the interval between choice trials, and the pharmacodynamics of the drug (in this case, heroin), are critical factors that impact choice behavior [ 70 , 71 ]. When comparing between two different rewards like food and heroin, EV is a useful metric, as it provides a normalization of the primary variable α, indicative of demand elasticity.…”

Mile high on heroin: Lessons on the opioid epidemic from the Mile High City

“…[2,8] Only studies that have employed extended drug access to exacerbate the addiction phenotype or drug priming, or those that have altered the price (e.g., increasing the number of lever presses required for the preferred reward) or delay in reward delivery (e.g., delaying the preferred reward) have managed to achieve a shift toward choosing drugs over natural rewards. [9,10] In our original manuscript describing these results, [1] we showed that even after abbreviated heroin access procedures, our rats still choose heroin over food approximately 50% of the time on average. Therefore, there are no obvious protocol differences between our study and others that offer a satisfying explanation for the surprising differences in behavioral outcomes.…”

Probing the decision-making mechanisms underlying choice between drug and nondrug rewards in rats

“…In contrast to saccharin, cocaine is generally selected with longer latencies during sampling, preventing the floor effect. Longer latencies to select cocaine could result from the ambivalent and anxiogenic effects of the drug [50–53] or from its delayed pharmacological effects on the brain [54]. Interestingly the gap between cocaine choice and sampling latencies was more pronounced in IND rats compared to CP rats.…”